Abstract
Evidence for the presence of an inherited metabolic disease is often derived from detailed clinical evaluation of the patient and examination of the family history. Important stumbling blocks in identifying an inherited metabolic disease include the fact that signs and symptoms are often nonspecific, leading to initial testing to exclude routine childhood illnesses and delaying consideration of metabolic disorders. Sometimes suspicion arises from unexpected pathological results of basic laboratory investigations and/or imaging. Absence of acute metabolic decompensation (e.g., hyperammonemia, hypoglycemia, overwhelming metabolic acidosis, anion gap) does not rule out an inherited metabolic disease.
Even when appropriately suspected, ordering physicians may be unfamiliar with important biochemical interrelationships and the appropriate diagnostic tests to order, occasionally leading to inappropriate sample collection and storage. Consultation and coordination with a licensed clinical biochemical genetics laboratory helps to insure that appropriate tests are ordered, the correct samples are obtained, and the limitations of the testing scheme are clearly defined prior to metabolic workup.
This chapter draws extensively on a previously published work: Hoffmann GF, Nyhan WL, Zschocke J, Kahler SG, Mayatepek E (2002) Inherited Metabolic Diseases – Biochemical Studies. Lippincott Williams & Wilkins, Core Handbooks in Pediatrics, pp. 95–109. The authors acknowledge the use of that material.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blau N, Hoffmann GF, Leonard J, Clarke JTR (eds) (2005) Physician’s guide to the treatment and follow-up of metabolic diseases. Springer, Berlin
Blau N, Duran M, Gibson KM, Dionisi-Vici C (eds) (2014) Physician’s guide to the diagnosis, treatment and follow-up of inherited metabolic diseases. Springer, Berlin
Zhang W, James PM, Ng B et al (2016) A Novel N-tetrasccharide in patients with congenital disorders of glycosylation including asparagine-linked glycosylation protein 1, phosphomannomutase 2 and phosphomannose isomerase deficiencies. Clin Chem 62(1):208–17
Hoffmann GF, Surtees RAH, Wevers RA (1998) Investigations of cerebrospinal fluid for neurometabolic disorders. Neuropediatrics 29:59–71
Nyhan WL, Barshop BA, Al-Aqeel A (2012) Atlas of inherited metabolic diseases, 3rd edn. Hodder-Arnold, London
Opladen T, Abu Seda B, Rassi A et al (2011) Diagnosis of tetrahydrobiopterin deficiency using filter paper blood spots: further development of the method and 5 years experience. J Inherit Metab Dis 34:819–826
Sadat MA, Moir S, Chun T-W et al (2014) Glycosylation, hypogammaglobulinemia, and resistance to viral infections. N Engl J Med 370:1615–1625
Xia B, Asif G, Arthur L, Pervaiz MA, Li X, Liu R, Cummings RD, He M (2013) Oligosaccharide analysis in urine by MALDI-TOF mass spectrometry for the diagnosis of lysosomal storage diseases. Clin Chem 59:1357–1368
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
He, M., Gibson, K.M. (2017). Biochemical Studies. In: Hoffmann, G., Zschocke, J., Nyhan, W. (eds) Inherited Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49410-3_37
Download citation
DOI: https://doi.org/10.1007/978-3-662-49410-3_37
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-49408-0
Online ISBN: 978-3-662-49410-3
eBook Packages: MedicineMedicine (R0)